Combined cardiac surgery and liver transplantation

Cardiovascular Diseases and Liver Transplantation

Volumn , Issue , 2011, Pages 139-156

  Raichlin, Eugenia ^a   Rosen, Charles B ^b   Dumitru, Ioana ^a   Daly, Richard C ^b   Kushwaha, Sudhir S ^b  

^a Department of Internal Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868133620     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Keeffe EB. Liver transplantation at the millennium. Past, present, and future. Clin. Liver Dis. 2000; 4(1): 241-55.
2. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59(6): 859-64.
3. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73(6): 901-6.
4. Plevak DJ. Stress echocardiography identifies coronary artery disease in liver transplant candidates. Liver Transpl. Surg. 1998; 4(4): 337-9.
5. Bizouarn P, Ausseur A, Desseigne P, Le Teurnier Y, Nougarede B, Train M, et al. Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann. Thorac. Surg. 1999; 67(5): 1334-8.
6. Klemperer JD, Ko W, Krieger KH, Connolly M, Rosengart TK, Altorki NK, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998; 65(1): 85-7.
7. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart Association. J. Am. Coll. Cardiol. 1999; 34(4): 1262-347.
8. Morris JJ, Hellman CL, Gawey BJ, Ramsay MA, Valek TR, Gunning TC, et al. Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J. Cardiothorac. Vasc. Anesth. 1995; 9(3): 322-32.
9. Abramov D, Tamariz MG, Fremes SE, Guru V, Borger MA, Christakis GT, et al. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann. Thorac. Surg. 2000; 70(1): 84-90.
10. Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after elective surgery in cirrhotic patients. J. Am. Coll. Surg. 2009; 208(1): 96-103.
11. Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, Tomoeda H, et al. Clinical outcome after cardiac operations in patients with cirrhosis Does off-pump coronary artery bypass grafting really preserve renal function. Ann. Thorac. Surg. 2004; 77(2): 500-5.
12. Plotkin JS, Johnson LB, Rustgi VK, Kuo PC, Liu AD. Dobutamine stress echocardiography for orthotopic liver transplant evaluation. Transplantation 2001; 71(6): 818.
13. Kaplan M, Cimen S, Kut MS, Demirtas MM. Cardiac operations for patients with chronic liver disease. Heart Surg. Forum 2002; 5(1): 60-5.
14. Suman A, Carey WD. Assessing the risk of surgery in patients with liver disease. Cleve Clin. J. Med. 2006; 73(4): 398-404.
15. Hirata N, Sawa Y, Matsuda H. Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery. J. Card Surg. 1999; 14(3): 172-7.
16. Downing SW, Edmunds LH, Jr. Release of vasoactive substances during cardiopulmonary bypass. An. Thorac. Surg. 1992; 54(6): 1236-43.
17. Hayashida N, Chihara S, Kashikie H, Tayama E, Yokose S, Akasu K, et al. Biological activity of endogenous atrial natriuretic peptide during cardiopulmonary bypass. Artif. Organs. 2000; 24(10): 833-8.
18. Schrier RW, Gurevich AK, Cadnapaphornchai MA. Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis. Semin. Nephrol. 2001; 21(2): 157-72.
19. Okano N, Miyoshi S, Owada R, Fujita N, Kadoi Y, Saito S, et al. Impairment of hepatosplanchnic oxygenation and increase of serum hyaluronate during normothermic and mild hypothermic cardiopulmonary bypass. Anesth. Analg. 2002; 95(2): 278-86.
20. Chukwuemeka A, Weisel A, Maganti M, Nette AF, Wijeysundera DN, Beattie WS, et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: a propensity score analysis. Ann. Thorac. Surg. 2005; 80(6): 2148-53.
21. Michalopoulos A, Alivizatos P, Geroulanos S. Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 1997; 44(15): 779-83.
22. Della Rocca G, Costa MG, Pompei L, Chiarandini P. The liver transplant recipient with cardiac disease. Transplant Proc. 2008; 40(4): 1172-4.
23. Therapondos G, Flapan AD, Plevris JN, Hayes PC. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl 2004; 10(12): 1441-53.
24. Kang YG, Freeman JA, Aggarwal S, DeWolf AM. Hemodynamic instability during liver transplantation. Transplant. Proc. 1989; 21(3): 3489-92.
25. Glauser FL. Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation. Chest 1990; 98(5): 1210-5.
26. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990; 12(3 pt1): 553-8.
27. Plotkin JS, Johnson LB, Rustgi V, Kuo PC. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl. 2000(4 Suppl 1): S53-6.
28. Kniepeiss D, Iberer F, Grasser B, Schaffellner S, Stadlbauer V, Stauber R, et al. Simultaneous coronary artery bypass grafting and orthotopic liver transplantation. Transpl. Int. 2003; 16(3): 207-9.
29. Lebbinck H, Bouchez S, Vereecke H, Vanoverbeke H, Troisi R, Reyntjens K. Sequential off-pump coronary artery bypass and liver transplantation. Transpl. Int. 2006; 19(5): 432-4.
30. Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T, et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl. 2004; 10(11): 1386-90.
31. Manas DM, Roberts DR, Heaviside DW, Chaudhry S, Tocewicz K, Hudson M, et al. Sequential coronary artery bypass grafting and orthotopic liver transplantation: a case report. Clin. Transplant. 1996; 10(3): 320-2.
32. Massad MG, Benedetti E, Pollak R, Chami YG, Allen BS, DeCastro MA, et al. Combined coronary bypass and liver transplantation: technical considerations. Ann. Thorac. Surg. 1998; 65(4): 1130-2.
33. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantatio. Liver Transpl. Surg. 1996; 2(6): 426-30.
34. Benedetti E, Massad MG, Chami Y, Wiley T, Layden TJ. Is the presence of surgically treatable coronary artery disease a contraindication to liver transplantation. Clin Transplant 1999; 13(1 Pt1): 59-61.
35. Wu YM, Voigt M, Rayhill S, Katz D, Chenhsu RY, Schmidt W, et al. Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases. Transplantation 2001; 72(8): 1389-94.
36. Burtenshaw AJ, Isaac JL. The role of trans-esophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl. 2006; 12(11): 1577-83.
37. Destephano CC, Harrison BA, Mordecai M, Crawford CC, Shine TS, Hewitt WR, et al. Anesthesia for Combined Cardiac Surgery and Liver Transplant. J. Cardiothorac. Vasc. Anesth. 2009; 24: 24.
38. Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann. Surg. 2002; 236(3): 315-22.
39. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61(8): 1180-8.
40. Mitruka SN, Griffith BP, Kormos RL, Hattler BG, Pigula FA, Shapiro R, et al. Cardiac operations in solid-organ transplant recipients. Ann. Thorac. Surg. 1997; 64(5): 1270-8.
41. Eckhoff DE, Frenette L, Sellers MT, McGuire BM, Contreras JL, Bynon JS, et al. Combined cardiac surgery and liver transplantation. Liver Transpl 2001; 7(1): 60-1.
42. Pollard RJ, Sidi A, Gibby GL, Lobato EB, Gabrielli A. Aortic stenosis with end-stage liver disease: prioritizing surgical and anesthetic therapies. J Clin Anesth 1998; 10(3): 253-61.
43. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc. Interv. 2009; 2(9): 828-33.
44. Mack M. Percutaneous mitral valve therapy: when? Which patients. Curr. Opin. Cardiol. 2009; 24(2): 125-9.
45. Lutter G, Quaden R, Osaki S, Hu J, Renner J, Edwards NM, et al. Off-pump transapical mitral valve replacement. Eur. J. Cardiothorac. Surg. 2009; 36(1): 124-8.
46. Shaw BW, Jr., Bahnson HT, Hardesty RL, Griffith BP, Starzl TE. Combined transplantation of the heart and liver. Ann. Surg. 1985; 202(6): 667-72.
47. Befeler AS, Schiano TD, Lissoos TW, Conjeevaram HS, Anderson AS, Millis JM, et al. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation 1999; 68(9): 1423-7.
48. Te HS, Anderson AS, Millis JM, Jeevanandam V, Jensen DM. Current state of combined heart-liver transplantation in the United States. J. Heart Lung Transplant. 2008; 27(7): 753-9.
49. Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant. Proc. 2005; 37(5): 2250-2.
50. Arpesella G, Chiappini B, Marinelli G, Mikus PM, Dozza F, Pierangeli A, et al. Combined heart and liver transplantation for familial amyloidotic polyneuropathy. J. Thorac. Cardiovasc. Surg. 2003; 125(5): 1165-6.
51. Grazi GL, Cescon M, Salvi F, Ercolani G, Ravaioli M, Arpesella G, et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transpl. 2003; 9(9): 986-92.
52. Lauro A, Diago Uso T, Masetti M, Di Benedetto F, Cautero N, De Ruvo N, et al. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning. Transplant. Proc. 2005; 37(5): 2214-20.
53. Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Cescon M, et al. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant. Proc. 2004; 36(3): 645-7.
54. Praseedom RK, McNeil KD, Watson CJ, Alexander GJ, Calne RY, Wallwork J, et al. Combined transplantation of the heart, lung, and liver. Lancet 2001; 358(9284): 812-3.
55. Ruygrok PN, Gane EJ, McCall JL, Chen XZ, Haydock DA, Munn SR. Combined heart and liver transplantation for familial amyloidosis. Intern. Med. J. 2001; 31(1): 66-7.
56. Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr. Opin. Neurol. 2004; 17(5): 615-20.
57. Surakomol S, Olson LJ, Rastogi A, Steers JL, Sterioff S, Daly RC, et al. Combined orthotopic heart and liver transplantation for genetic hemochromatosis. J. Heart Lung. Transplant. 1997 May; (16): 5-573.
58. Fricker FJ, Griffith BP, Hardesty RL, Trento A, Gold LM, Schmeltz K, et al. Experience with heart transplantation in children. Pediatrics 1987; 79(1): 138-46.
59. Gandhi SK, Reyes J, Webber SA, Siewers RD, Pigula FA. Case report of combined pediatric heart-lung-liver transplantation. Transplantation 2002; 73(12): 1968-9.
60. Olivieri NF, Liu PP, Sher GD, Daly PA, Greig PD, McCusker PJ, et al. Brief report: combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N. Engl. J. Med. 1994; 330(16): 1125-7.
61. Detry O, Honore P, Meurisse M, Defraigne JO, Defechereux T, Sakalihasan N, et al. Advantages of inferior vena caval flow preservation in combined transplantation of the liver and heart. Transpl. Int. 1997; 10(2): 150-1.
62. Haynes H, Farroni J. Successful combined heart-liver transplantation in a patient with hemochromatosis. Prog. Transplant. 2004; 14(1): 39-40.
63. Offstad J, Schrumpf E, Geiran O, Soreide O, Simonsen S. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin. Transplant. 2001; 15(6): 432-6.
64. Rela M, Muiesan P, Heaton ND, Corbally M, Hajj H, Mowat AP, et al. Orthotopic liver transplantation for hepatic-based metabolic disorders. Transpl. Int. 1995; 8(1): 41-4.
65. Revell SP, Noble-Jamieson G, Johnston P, Rasmussen A, Jamieson N, Barnes ND. Liver transplantation for homozygous familial hypercholesterolaemia. Arch. Dis. Child. 1995; 73(5): 456-8.
66. Valdivielso P, Escolar JL, Cuervas-Mons V, Pulpon LA, Chaparro MA, Gonzalez-Santos P. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann. Intern. Med. 1988; 108(2): 204-6.
67. Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transpl. 2004; 10(12): 1539-44.
68. Hennessey T, Backman SB, Cecere R, Lachapelle K, de Varennes B, Ergina P, et al. Combined heart and liver transplantation on cardiopulmonary bypass: report of four cases. Can. J. Anaesth. 2010; 57(4): 355-60.
69. Dennis CM, McNeil KD, Dunning J, Stewart S, Friend PJ, Alexander G, et al. Heart-lung-liver transplantation. J Heart Lung Transplant 1996; 15(5): 536-8.
70. Couetil JP, Houssin DP, Soubrane O, Chevalier PG, Dousset BE, Loulmet D, et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J. Thorac. Cardiovasc. Surg. 1995; 110(5): 1415-22; discussion 22-3.
71. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, et al. Combined heart and liver transplantation: a single-center experience. Transplantation 2009; 88(2): 219-25.
72. Figuera D, Ardaiz J, Martin-Judez V, Pulpon LA, Pradas G, Cuervas-Mons V, et al. Combined transplantation of heart and liver from two different donors in a patient with familial type IIa hypercholesterolemia. J. Heart Transplant. 1986; 5(4): 327-9.
73. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989 Mar; (47): 3-524.
74. McMillan RW, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, McDonald JC. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin. Transplant. 1997 Apr; (11): 2-98.
75. Vogel W, Steiner E, Kornberger R, Koller J, Spielberger M, Aulitzky W, et al. Preliminary results with combined hepatorenal allografting. Transplantation 1988 Feb; (45): 2-491.
76. Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, et al. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 2007; 84(4): 467-74.
77. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLT) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001 Dec 27; 72(12): 1934-9.
78. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a non-renal organ. N. Engl. J. Med. 2003 Sep 4; 349(10): 931-40.
79. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007; 116(23): 2726-33.
80. Berroeta C, Flament F, Lathyris D, Provenchere S, Paquin S, Desmonts JM, et al. Pulmonary embolism: an uncommon cause of dyspnea after heart transplantation. J. Cardiothorac. Vasc. Anesth. 2006; 20(2): 236-8.
81. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990; 12(3): 553-8.
82. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998 Jul 27; 66(2): 229-33.
83. Westermark P, Sletten K, Johansson B, Cornwell GG, 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. U S A. 1990 Apr; (87): 7-2843.
84. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem. Biophys. Res. Commun. 2000 Aug 11; 274(3): 702-6.
85. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998 Apr 15; 65(7): 918-25.
86. Kotani N, Hattori T, Yamagata S, Tokuda T, Shirasawa A, Yamaguchi S, et al. Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid. 2002 Mar; (9): 1-31.
87. Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl. 2003 Dec; (9): 12-1273.
88. Garcia-Herola A, Prieto M, Pascual S, Berenguer M, Lopez-Viedma B, Mir J, et al. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl. Surg. 1999 May; (5): 3-246.
89. Azoulay D, Samuel D, Castaing D, Adam R, Adams D, Said G, et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J. Am. Coll. Surg. 1999; 189(6): 584-93.